Viewing StudyNCT06479954

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 10:58 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06479954
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-28
First Post: 2024-06-24
Brief Title: Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use
Sponsor: Pfizer
Organization: Pfizer
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Relapsed and Refractory Multiple Myeloma RRMM
Keywords:
Name View
RRMM View